CREXONT ER
IPX203-401-23
Approved small_molecule active
Quick answer
CREXONT ER for Parkinson Disease is a Approved program (small_molecule) at Amneal Pharmaceuticals with 2 ClinicalTrials.gov record(s).
Program details
- Company
- Amneal Pharmaceuticals
- Indication
- Parkinson Disease
- Phase
- Approved
- Modality
- small_molecule
- Status
- active